SEARCH RESULTS FOR: (*Forged New Hampshire driver*)(11306 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
No Description
Arj Medical, Inc.
PPUBTA-02
In Commercial Distribution
- 00860001810363 ()
- Infrared spectrometry breath analyser IVD
No Description
Arj Medical, Inc.
PPUBTK
In Commercial Distribution
- 00860001810325 ()
- Carbon isotope breath test kit IVD
The SpineSeal Spine Sealant is indicated as an adjuct to sutured dural repair during spine surgery to provide a watertight closure.
Pramand LLC
SS-2055
In Commercial Distribution
- 20860010683723 ()
- 00860010683729 ()
SS-2055
- Dura mater sealant
The DETOUR System is indicated for use for percutaneous revascularization in patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis >70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments. The DETOUR System, or any of its components, is not for use in the coronary and cerebral vasculature.
PQ Bypass, Inc.
ENDOCROSS
In Commercial Distribution
- 00860008946409 ()
ENDOCROSS
- Vascular guide-catheter, single-use
MI Cancer Seek is a next-generation sequencing (NGS) based in vitro diagnostic (IVD) device using total nucleic acid (TNA) isolated from formalin-fixed paraffin embedded (FFPE) tumor tissue specimens for the detection of single nucleotide variants (SNVs) and insertions and deletions (indels) in 228 genes, microsatellite instability (MSI) tumor
mutational burden (TMB) in patients with previously diagnosed solid tumors, and copy number amplification (CNA) in one gene in patients with breast cancer. MI Cancer Seek is intended as a companion diagnostic to identify patients who may benefit from treatment with the targeted therapies listed in the approved therapeutic product labeling. Additionally, MI Cancer Seek is intended to provide tumor mutational profiling to be used by qualified healthcare professionals in accordance with professional oncology guidelines for cancer patients with previously diagnosed solid malignant neoplasms. Genomic findings other than those listed as companion diagnostic indications are not prescriptive or conclusive for labeled use of any specific therapeutic product.
CARIS MPI, INC.
MCS000
In Commercial Distribution
- 00860008613325 ()
- Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
Sterilization Tray
Lumicell, Inc.
900-00209
In Commercial Distribution
- 00860008537898 ()
- Device sterilization/disinfection container, reusable
No Description
EXACT SCIENCES CORPORATION
100730
In Commercial Distribution
- 00858637005994 ()
- Faecal occult blood IVD, control
No Description
EXACT SCIENCES CORPORATION
100727
In Commercial Distribution
- 00858637005987 ()
- Faecal occult blood IVD, reagent
No Description
EXACT SCIENCES CORPORATION
100728
In Commercial Distribution
- 00858637005970 ()
- Exogenous DNA/RNA internal control IVD, kit
No Description
EXACT SCIENCES CORPORATION
100676
In Commercial Distribution
- 00858637005949 ()
- Faecal specimen collection kit IVD, home-use